Trial Outcomes & Findings for The Association Between Decreasing Labor Analgesia Epidural Infusion and Forceps Delivery (NCT NCT00443560)

NCT ID: NCT00443560

Last Updated: 2014-04-14

Results Overview

At the request of the obstetric provider, second stage analgesia density was decreased by decreasing the basal infusion rate if there was dissatisfaction with the progress of labor or a perceived inability to push. The basal infusion was never totally discontinued.

Recruitment status

COMPLETED

Target enrollment

2162 participants

Primary outcome timeframe

Second stage of labor up to 3 hours

Results posted on

2014-04-14

Participant Flow

The Obstetric Anesthesiology Database was used to identify parturients from the Labor and Delivery Unit of Prentice Women's Hospital of Northwestern Memorial Hospital who qualified for the study between January 2004 and October 2005.

Participant milestones

Participant milestones
Measure
Instrumental Vaginal Delivery (IVD)
Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.
Spontaneous Vaginal Delivery (SVD)
The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.
Overall Study
STARTED
1081
1081
Overall Study
COMPLETED
1021
1051
Overall Study
NOT COMPLETED
60
30

Reasons for withdrawal

Reasons for withdrawal
Measure
Instrumental Vaginal Delivery (IVD)
Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.
Spontaneous Vaginal Delivery (SVD)
The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.
Overall Study
No intrathecal dose
58
26
Overall Study
Multiple pregnancies or fetal demise
2
4

Baseline Characteristics

The Association Between Decreasing Labor Analgesia Epidural Infusion and Forceps Delivery

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Instrumental Vaginal Delivery (IVD)
n=1081 Participants
Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.
Spontaneous Vaginal Delivery (SVD)
n=1081 Participants
The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.
Total
n=2162 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Categorical
Between 18 and 65 years
1081 Participants
n=99 Participants
1081 Participants
n=107 Participants
2162 Participants
n=206 Participants
Age, Categorical
>=65 years
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Age, Continuous
32 years
STANDARD_DEVIATION 3 • n=99 Participants
31 years
STANDARD_DEVIATION 3 • n=107 Participants
31 years
STANDARD_DEVIATION 3 • n=206 Participants
Sex: Female, Male
Female
1081 Participants
n=99 Participants
1081 Participants
n=107 Participants
2162 Participants
n=206 Participants
Sex: Female, Male
Male
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Region of Enrollment
United States
1081 participants
n=99 Participants
1081 participants
n=107 Participants
2162 participants
n=206 Participants

PRIMARY outcome

Timeframe: Second stage of labor up to 3 hours

Population: Analysis was per protocal

At the request of the obstetric provider, second stage analgesia density was decreased by decreasing the basal infusion rate if there was dissatisfaction with the progress of labor or a perceived inability to push. The basal infusion was never totally discontinued.

Outcome measures

Outcome measures
Measure
Instrumental Vaginal Delivery (IVD)
n=1021 Participants
Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.
Spontaneous Vaginal Delivery (SVD)
n=1051 Participants
The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.
Number of Parturients With a Decrease in the Infusion of Epidural Analgesia During Second Stage of Labor
146 participants
51 participants

SECONDARY outcome

Timeframe: Supplemental analgesia in first stage of labor (<24 hours)

Population: Analysis was per protocol

Pain not responding to epidural analgesia in the first stage of labor was treated with bolus dose of bupivacaine 1.25 mg/mL or lidocaine 10 mg/mL, 10 to 15 mL. If pain relief was obtained the infusion concentration was increased. If the patient had no pain relief following the bolus injection, the epidural catheter was replaced.

Outcome measures

Outcome measures
Measure
Instrumental Vaginal Delivery (IVD)
n=1021 Participants
Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.
Spontaneous Vaginal Delivery (SVD)
n=1051 Participants
The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.
Number of Participants With Breakthrough Pain in the First Stage of Labor
Supplemental bolus
802 participants
243 participants
Number of Participants With Breakthrough Pain in the First Stage of Labor
Infusion increase
149 participants
87 participants
Number of Participants With Breakthrough Pain in the First Stage of Labor
Concentration increase
32 participants
19 participants

SECONDARY outcome

Timeframe: Time form initiation of labor analgesia to delivery (up to 24 hours)

Population: Analysis was per protocal

Time in minutes from initiation of labor analgesia until delivery of the infant

Outcome measures

Outcome measures
Measure
Instrumental Vaginal Delivery (IVD)
n=1021 Participants
Instrumental vaginal delivery (IVD) is attempted to prevent fetal hypoxia if the second stage of labor is prolonged. It includes forceps and vacuum extractions.
Spontaneous Vaginal Delivery (SVD)
n=1051 Participants
The control group consisted of parturients who had a spontaneous vaginal delivery (SVD)in the same 24 hour period who were case-matched for gravidity and parity.
Duration of Labor Analgesia
420 minutes
Interval 300.0 to 570.0
300 minutes
Interval 210.0 to 420.0

Adverse Events

Instrumental Vaginal Delivery (IVD)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Spontaneous Vaginal Delivery (SVD)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Robert J. McCarthy, PharmD

Northwestern University Feinberg School of Medicine

Phone: 312-926-9015

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place